Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

By M. Sarwal, M. Chua, N. Kambham, S. Hsieh, Thomas S. Satterwhite, M. Masek, O. Salvatierra. New England Journal of Medicine, 2003

709 citations recorded by the source corpus.

Subfields: Immunology, Transplantation

View Paper: https://www.semanticscholar.org/paper/35c8da00a988ad2a4ee8fee6c60c0f9093c8bf58

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. T. Randall
2. Philip F. Halloran

In Transplantation

1. Philip F. Halloran

Citations in the corpus

• Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’) (2007, background): “In addition, no obvious differential gene expression could be defined in cases of allograft fibrosis due to different causes (51).”
• Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action (2006, background): “showing that CD20 gene expression was associated with worse prognosis (53).”
• Effector and regulatory B cells: modulators of CD4+ T cell immunity (2010, background): “However, it is clear, at least in the case of kidney transplants, that CD20 + B cells can be found in the kidney undergoing rejectio”